J&J Study Predicted 37% Hip-Failure Rate

One year after Johnson & Johnson pulled 93,000 metal hip implants from the market, the company internally estimated that 37 percent of the devices would fail within 4.6 years, according to newly unsealed court records.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.